NCT01667120View on ClinicalTrials.gov

The Use of Ketorolac in Surgical Neonates

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Postoperative Pain Control in Surgical Neonates
Interventions
DRUG

Ketorolac

Ketorolac 0.5mg/kg IV q8h x 72h.

DRUG

placebo

0.9% normal saline 1ml/kg

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Nationwide Children's Hospital

OTHER

NCT01667120 - The Use of Ketorolac in Surgical Neonates | Biotech Hunter | Biotech Hunter